• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌和肺鳞状细胞癌中肿瘤血管生成的免疫组织化学评估

Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung.

作者信息

Sikora J, Słodkowska J, Radomyski A, Giedronowicz D, Kobos J, Kupis W, Rudzinski P

机构信息

National Institute of Tuberculosis and Lung Diseases, Warsaw and Medical Academy, Lódź.

出版信息

Rocz Akad Med Bialymst. 1997;42 Suppl 1:271-9.

PMID:9337544
Abstract

Experimental studies revealed that growth and expansion of solid tumours depend on angiogenesis. Angiogenesis is very important factor for neoplastic metastasis. The presence of the metastasis is an ominous prognostic factor for many tumours, also for lung cancer. Studies of tumour microvessel density in resected non-small lung cancers have not given convincing data about value of angiogenesis. Only few reports regarded the association with angiogenesis in different histological types in lung carcinoma. Samples of 35 adenocarcinomas and 41 squamous cell resected, primary lung carcinomas were studied. Paraffin sections of tumours were stained immunohistochemically by antibody against endothelial marker CD34. Angiogenesis intensity was measured in the areas of the most active fields of tumour neovascularization. Microvessel density (MD) was higher in adenocarcinoma comparing to squamous cell cancer, but the difference was not statistically significant (p = 0,095). The groups of various stage of extension of disease in each histological type were compared-MD correlated with lymph node metastasis (p = 0,003) in the adenocarcinoma, whilst in squamous cell can cer differences between various groups of nodal involvement were not statistically significant (p = 0,53 and p = 0,22 respectively). Our results suggest that more intensive angiogenesis in adenocarcinoma could be more important factor for metastasis of adenocarcinoma than for squamous tumours. In the latter group angiogenesis may be more important for growth of squamous cell cancers, while the spread of squamous tumours may depend on other mechanisms.

摘要

实验研究表明,实体瘤的生长和扩展依赖于血管生成。血管生成是肿瘤转移的一个非常重要的因素。转移的存在对许多肿瘤来说都是一个不祥的预后因素,对肺癌也是如此。对切除的非小细胞肺癌中的肿瘤微血管密度进行研究,尚未得出关于血管生成价值的确凿数据。仅有少数报告涉及肺癌不同组织学类型与血管生成的关联。对35例腺癌和41例切除的原发性肺鳞癌样本进行了研究。肿瘤石蜡切片用抗内皮标志物CD34的抗体进行免疫组织化学染色。在肿瘤新生血管最活跃的区域测量血管生成强度。腺癌的微血管密度(MD)高于鳞癌,但差异无统计学意义(p = 0.095)。比较了每种组织学类型中疾病不同扩展阶段的组——腺癌中MD与淋巴结转移相关(p = 0.003),而在肺鳞癌中,不同淋巴结受累组之间的差异无统计学意义(分别为p = 0.53和p = 0.22)。我们的结果表明,腺癌中更强烈的血管生成可能对腺癌转移比对鳞癌更重要。在鳞癌组中,血管生成可能对鳞状细胞癌的生长更重要,而鳞状肿瘤的扩散可能取决于其他机制。

相似文献

1
Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung.肺腺癌和肺鳞状细胞癌中肿瘤血管生成的免疫组织化学评估
Rocz Akad Med Bialymst. 1997;42 Suppl 1:271-9.
2
Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage.关于肺癌血管生成强度与肿瘤组织学类型及临床分期相关性的研究。
Rocz Akad Med Bialymst. 1997;42 Suppl 1:254-70.
3
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.血管内皮生长因子、血小板衍生内皮细胞生长因子与非小细胞肺癌中的血管生成
Br J Cancer. 2000 Apr;82(8):1427-32. doi: 10.1054/bjoc.1999.1129.
4
Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.抗VIII因子和抗CD31免疫染色评估非小细胞肺癌血管生成的比较性评价
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2485-92.
5
Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.血管生成素-2信使核糖核酸在非小细胞肺癌中的过表达:与血管生成及不良预后的关联
Oncol Rep. 2004 Oct;12(4):849-53.
6
Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.血管内皮生长因子(VEGF)及其两种受体(VEGF-R1-Flt1和VEGF-R2-Flk1/KDR)在非小细胞肺癌(NSCLC)中的表达:与血管生成和生存的相关性
J Pathol. 1999 Aug;188(4):369-77. doi: 10.1002/(SICI)1096-9896(199908)188:4<369::AID-PATH381>3.0.CO;2-X.
7
Prognostic significance of microvascularization in cases of operated lung cancer.手术治疗的肺癌病例中微血管形成的预后意义
Eur J Cardiothorac Surg. 2005 Jun;27(6):1106-11. doi: 10.1016/j.ejcts.2005.01.036. Epub 2005 Mar 2.
8
Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.非小细胞肺癌患者循环内皮祖细胞数量和肿瘤内微血管密度:腺癌组织学亚型之间血管生成状态的差异。
J Thorac Oncol. 2012 Mar;7(3):503-11. doi: 10.1097/JTO.0b013e318241780e.
9
Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.碱性成纤维细胞生长因子(bFGF)和血管内皮生长因子(VEGF)水平,作为非小细胞肺癌的预后指标。
Eur J Cardiothorac Surg. 2004 Mar;25(3):443-8. doi: 10.1016/j.ejcts.2003.11.031.
10
Different angiogenic pathways in human cervical cancers.人类宫颈癌中不同的血管生成途径。
Gynecol Oncol. 1998 Jan;68(1):38-44. doi: 10.1006/gyno.1997.4876.

引用本文的文献

1
Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance.I-IIIA期肺鳞状细胞癌中不同类型的肿瘤微血管及其临床意义。
World J Clin Oncol. 2024 May 24;15(5):614-634. doi: 10.5306/wjco.v15.i5.614.
2
Angiogenesis inhibitors in lung cancer.肺癌中的血管生成抑制剂
Curr Oncol Rep. 2002 Jul;4(4):325-33. doi: 10.1007/s11912-002-0008-0.